Brief: Mabpharm Posts HY Loss Attributable RMB 145.2 MLN
27/08/2021 11:41
Aug 27 (Reuters) - Mabpharm Ltd 2181.HK :
* HY LOSS ATTRIBUTABLE RMB 145.2 MILLION VERSUS LOSS OF RMB
54.2
MILLION
Source text for Eikon: ID:nHKS9vgpxG
Further company coverage: 2181.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mabpharm
See all newsBrief: Mabpharm Says NMPA Approves CMAB807X (Denosumab Injection) NDA
Brief: Mabpharm Says NMPA Approves Cmab807 (Denosumab Injection) NDA
Brief: Mabpharm FY Profit And Total Comprehensive Income Attributable Rmb57.1 Million
Brief: Mabpharm Says Approval From Drug Regulatory Authority Of Pakistan On Registration Of Core Product,CMAB008
Brief: Mabpharm Says Approval From Indonesian National Agency Of Drug And Food Control Of CMAB008